Literature DB >> 27062697

Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.

Bin-Hui Xie1, Xiao He1, Rui-Xi Hua2, Bing Zhang3, Guo-Sheng Tan4, Shi-Qiu Xiong5, Liang-Shuai Liu4, Wei Chen4, Jian-Yong Yang4, Xiao-Nong Wang1, He-Ping Li2,4.   

Abstract

microRNAs (miRNAs) dysregulation is widely involved in cancer progression and contributed to sustained cell proliferation by directly targeting multiple targets. Therefore, better understanding the underlying mechanism of miRNA in carcinogenesis may improve diagnostic and therapeutic strategies for malignancy. In our study, we found that mir-765 is upregulated in both hepatocellular carcinoma (HCC) cell lines and tissues, compared to human normal liver cell line and adjacent non-cancerous tissues, respectively. Overexpression of mir-765 increased HCC cells proliferation and tumorigenicity, whereas inhibition of mir-765 reverses this effect. Furthermore, we demonstrated that INPP4B as a direct target of mir-765 and ectopic expression of mir-765 repressed INPP4B expression, resulting in upregulation of p-AKT, Cyclin D1, and downregulation of p-FOXO3a, p21 expression in HCC. Strikingly, we found that silencing the expression of INPP4B is the essential biological function of miR-765 during HCC cell proliferation. Collectively, our findings reveal that miR-765 is a potential onco-miR that participates in carcinogenesis of human HCC by suppressing INPP4B expression, and might represent a potential therapeutic target for HCC patients.

Entities:  

Keywords:  INPP4B; human hepatocellular carcinoma; miR-765; proliferation

Mesh:

Substances:

Year:  2016        PMID: 27062697     DOI: 10.3233/CBM-160579

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  24 in total

1.  Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis.

Authors:  Xuan Zhu; Xing Niu; Chunlin Ge
Journal:  Cancer Biol Ther       Date:  2019-02-11       Impact factor: 4.742

2.  MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.

Authors:  Hongbin Bao; Xinguo Li; Hengli Li; Hongli Xing; Binghui Xu; Xianfeng Zhang; Zhaoming Liu
Journal:  J Biosci       Date:  2017-03       Impact factor: 1.826

3.  MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.

Authors:  Zhaozhou Ren; Ming He; Tao Shen; Kejia Wang; Qingjie Meng; Xiangxu Chen; Long Zhou; Yanshuo Han; Chao Ji; Shengnan Liu; Qin Fu
Journal:  Cancer Biol Ther       Date:  2019-11-12       Impact factor: 4.742

4.  The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.

Authors:  Peng-Hsu Chen; Chia-Hsiung Cheng; Chwen-Ming Shih; Kuo-Hao Ho; Cheng-Wei Lin; Chin-Cheng Lee; Ann-Jeng Liu; Cheng-Kuei Chang; Ku-Chung Chen
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

5.  Prediction of miRNA-disease Associations using an Evolutionary Tuned Latent Semantic Analysis.

Authors:  Denis Pallez; Julien Gardès; Claude Pasquier
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

6.  Serum MicroRNA profile in patients with colon adenomas or cancer.

Authors:  Yajie Zhang; Min Li; Yijiang Ding; Zhimin Fan; Jinchun Zhang; Hongying Zhang; Bin Jiang; Yong Zhu
Journal:  BMC Med Genomics       Date:  2017-04-20       Impact factor: 3.063

7.  miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis.

Authors:  Chunhui Sun; Xun Yao; Qingyu Jiang; Xiuyong Sun
Journal:  Oncol Lett       Date:  2018-06-15       Impact factor: 2.967

Review 8.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

9.  Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer.

Authors:  Teng-Fei Yin; Dong-Yan Zhao; Yuan-Chen Zhou; Qian-Qian Wang; Shu-Kun Yao
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

10.  MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4.

Authors:  Li Liu; Xun Cai; Enqiang Liu; Xia Tian; Chuan Tian
Journal:  Oncotarget       Date:  2017-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.